June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) clinical program evaluating the novel Shockwave SkyRunner Carotid Intravascular ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
June 29, 2026 — Konica Minolta, Inc. has announced that a research group has developed a simple and rapid technique for ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
A physical exam and echocardiogram have been the traditional tools for diagnosing aortic stenosis. Yet many patients ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...
May 28, 2026 — Coredio has announced that the U.S. Food and Drug Administration (FDA) has granted its Cardiac ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
June 29, 2026